Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals
Antimicrob Chemother. 2016 Dec 20. pii: dkw504. doi: 10.1093/jac/dkw504. Switching from PIs to dolutegravir in virologically suppressed HIV-infected individuals has not been assessed. The principal aim was to assess the evolution of bone mineral density … Leer más